{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:55:58Z","timestamp":1783702558300,"version":"3.55.0"},"reference-count":33,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.3892\/or.2011.1613","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T07:21:33Z","timestamp":1325229693000},"page":"1058-1064","source":"Crossref","is-referenced-by-count":8,"title":["Upregulation of \u03b22-microglobulin expression in progressive human oral squamous cell carcinoma"],"prefix":"10.3892","volume":"27","author":[{"given":"QIAN","family":"JIANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SDEK","family":"PATIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DONG-XIA","family":"YE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HONG-YA","family":"PAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PIN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHI-YUAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2011,12,30]]},"reference":[{"key":"key20180107213811_b1-or-27-04-1058","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1349-7006.2008.00769.x","article-title":"Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma","volume":"99","author":"Imai","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107213811_b2-or-27-04-1058","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.oraloncology.2008.01.006","article-title":"Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes","volume":"44","author":"Scully","year":"2008","journal-title":"Oral Oncol"},{"key":"key20180107213811_b3-or-27-04-1058","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1097\/00029330-200810010-00003","article-title":"Beta-catenin expression pattern in primary oral squamous cell carcinoma","volume":"121","author":"Cai","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"key20180107213811_b4-or-27-04-1058","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6604698","article-title":"Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion","volume":"99","author":"Chen","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180107213811_b5-or-27-04-1058","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drudis.2008.11.001","article-title":"Beta2-microglobulin: emerging as a promising cancer therapeutic target","volume":"14","author":"Shi","year":"2009","journal-title":"Drug Discov Today"},{"key":"key20180107213811_b6-or-27-04-1058","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.arrt.2003.11.003","article-title":"Beta-2 microglobulin in ESRD: an in-depth review","volume":"10","author":"Winchester","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"key20180107213811_b7-or-27-04-1058","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4049\/jimmunol.176.1.217","article-title":"Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin","volume":"176","author":"Margalit","year":"2006","journal-title":"J Immunol"},{"key":"key20180107213811_b8-or-27-04-1058","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.159.10.4781","article-title":"Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism","volume":"159","author":"Christianson","year":"1997","journal-title":"J Immunol"},{"key":"key20180107213811_b9-or-27-04-1058","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<370::AID-IMMU370>3.0.CO;2-W","article-title":"Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains","volume":"28","author":"Hoglund","year":"1998","journal-title":"Eur J Immunol"},{"key":"key20180107213811_b10-or-27-04-1058","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1158\/0008-5472.CAN-06-1996","article-title":"Beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107213811_b11-or-27-04-1058","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1158\/1078-0432.CCR-06-2060","article-title":"Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis","volume":"12","author":"Nomura","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107213811_b12-or-27-04-1058","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/1078-0432.CCR-07-2063","article-title":"The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients","volume":"14","author":"Tsimberidou","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107213811_b13-or-27-04-1058","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1158\/1078-0432.CCR-08-0793","article-title":"Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells","volume":"14","author":"Huang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107213811_b14-or-27-04-1058","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ijom.2006.01.017","article-title":"Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7","volume":"35","author":"Sdek","year":"2006","journal-title":"Int J Oral Maxillofac Surg"},{"key":"key20180107213811_b15-or-27-04-1058","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1600-0714.2008.00678.x","article-title":"Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma","volume":"38","author":"Zhang","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"key20180107213811_b16-or-27-04-1058","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9440(10)65321-7","article-title":"Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression","volume":"154","author":"Kageshita","year":"1999","journal-title":"Am J Pathol"},{"key":"key20180107213811_b17-or-27-04-1058","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000217946","article-title":"The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients","volume":"16","author":"Klein","year":"1995","journal-title":"Tumour Biol"},{"key":"key20180107213811_b18-or-27-04-1058","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.juro.2007.03.203","article-title":"Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma","volume":"178","author":"Freeman","year":"2007","journal-title":"J Urol"},{"key":"key20180107213811_b19-or-27-04-1058","first-page":"425","article-title":"Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease","volume":"67","author":"Nissen","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"key20180107213811_b20-or-27-04-1058","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/modpathol.3800477","article-title":"Gastrointestinal beta2microglobulin amyloidosis in hemodialysis patients: biochemical analysis of amyloid proteins in small formalin-fixed paraffin-embedded tissue specimens","volume":"18","author":"Kaplan","year":"2005","journal-title":"Mod Pathol"},{"key":"key20180107213811_b21-or-27-04-1058","first-page":"4765","article-title":"Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma","volume":"20","author":"Lee","year":"2000","journal-title":"Anticancer Res"},{"key":"key20180107213811_b22-or-27-04-1058","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00277-009-0841-4","article-title":"Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma","volume":"89","author":"Kim","year":"2009","journal-title":"Ann Hematol"},{"key":"key20180107213811_b23-or-27-04-1058","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2141.2009.07699.x","article-title":"Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate","volume":"145","author":"Delgado","year":"2009","journal-title":"Br J Haematol"},{"key":"key20180107213811_b24-or-27-04-1058","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3324\/haematol.11502","article-title":"Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study","volume":"92","author":"Federico","year":"2007","journal-title":"Haematologica"},{"key":"key20180107213811_b25-or-27-04-1058","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.leukres.2006.02.013","article-title":"Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease","volume":"31","author":"Albitar","year":"2007","journal-title":"Leuk Res"},{"key":"key20180107213811_b26-or-27-04-1058","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1073\/pnas.97.8.4204","article-title":"Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice","volume":"97","author":"Sousa","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107213811_b27-or-27-04-1058","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1172\/JCI498","article-title":"Beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma","volume":"101","author":"Hicklin","year":"1998","journal-title":"J Clin Invest"},{"key":"key20180107213811_b28-or-27-04-1058","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00262-007-0362-8","article-title":"Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma","volume":"57","author":"Mehta","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107213811_b29-or-27-04-1058","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-3083.2009.02276.x","article-title":"Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy","volume":"70","author":"del Campo","year":"2009","journal-title":"Scand J Immunol"},{"key":"key20180107213811_b30-or-27-04-1058","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-0039.2004.00291.x","article-title":"High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis","volume":"64","author":"Koene","year":"2004","journal-title":"Tissue Antigens"},{"key":"key20180107213811_b31-or-27-04-1058","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1399-0039.1999.540304.x","article-title":"HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas","volume":"54","author":"Feenstra","year":"1999","journal-title":"Tissue Antigens"},{"key":"key20180107213811_b32-or-27-04-1058","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccr.2006.08.025","article-title":"Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies","volume":"10","author":"Yang","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180107213811_b33-or-27-04-1058","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood-2007-06-094417","article-title":"Anti-beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts","volume":"110","author":"Yang","year":"2007","journal-title":"Blood"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2011.1613\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T18:17:24Z","timestamp":1686593844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2011.1613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,30]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,12,30]]},"published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.3892\/or.2011.1613"],"URL":"https:\/\/doi.org\/10.3892\/or.2011.1613","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,30]]}}}